CQT.AX has a highly leveraged capital structure, with a debt-to-equity ratio of 5.79, indicating a significant reliance on debt financing. The company's liquidity position is rated as medium, with…
Crest Group Bhd has a liquidity position that could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of data limits the ab…
Curanex Pharmaceuticals Inc operates with a market capitalization of $8.88 million and a market price of $0.3129 per share, indicating a small-cap profile. The company has no dilution risk in the n…
Dicera Holdings JSC maintains a conservative capital structure with a debt-to-equity ratio of 0.04 and a current ratio of 1.43. The balance sheet shows total assets of 2,473,241,721,520 VND against…
DEVA.IS has a liquidity position that is characterized by a current ratio of 1.65, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's…
HVAX Technologies Ltd maintains a debt-to-equity ratio of 0.96, indicating a balanced capital structure with moderate leverage. The company's current ratio of 1.23 suggests it has sufficient short-…
JMI Syringes & Medical Devices Ltd maintains a strong liquidity position, with a current ratio of 5.12, indicating that it holds significantly more current assets than current liabilities. However,…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.08, indicating a conservative leverage position. Its liquidity is assessed as medium, with a current ratio of 3.6…
MGX Resources Ltd has an equal number of basic and diluted shares outstanding, with 1,180,428,735 shares in both categories, indicating no immediate dilution pressure from stock options or converti…
Navana Pharmaceuticals maintains a capital structure with a debt-to-equity ratio of 1.09, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, w…
OCPH.CA maintains a relatively strong liquidity position, with a current ratio of 2.06, indicating that it has sufficient current assets to cover its current liabilities. However, the company's net…
PBC.HNO has a debt-to-equity ratio of 1.1, indicating a moderate reliance on debt financing, and a current ratio of 0.5, suggesting potential liquidity constraints in the short term. The company's…
Panacea Biotec has a strong liquidity position, with cash and equivalents amounting to ₹923.1 million, representing 74.5% of total assets. The company's liquidity FPT (free cash flow to total liabi…
The company maintains a strong liquidity position, with a free cash flow of 64,430,468,749.9999 VND and a debt-to-equity ratio of 0.15, indicating a relatively low reliance on debt financing. Its t…
Prime Securities Ltd maintains a strong liquidity position, with cash and equivalents amounting to INR 379.6 million, representing 23.9% of total assets. The company has no long-term debt, and its…
The company's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. This is supported by a strong current ratio of 14.01, suggesting robust…
Rhone Ma Holdings Bhd maintains a conservative capital structure with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. The company's liquidity position is characterized…
Cartesian Therapeutics operates with a negative equity position of -$126.24 million and no long-term debt, indicating a capital structure reliant on equity and cash reserves. The company holds $125…
The company's capital structure is characterized by a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position. However, the liquidity risk is rated as medium, with a cu…
Revium Rx has a fully diluted share count of 61,321,100 shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock options or converti…
YASS.NS maintains a strong liquidity position with a current ratio of 8.5, indicating the company can easily cover its short-term liabilities with its current assets. However, the company has a neg…
Zhejiang Haisen maintains a strong liquidity position, with a current ratio of 11.01, indicating that it holds significantly more current assets than current liabilities. However, the company repor…
The company's capital structure is characterized by a high debt-to-equity ratio of 1.67, indicating a significant reliance on debt financing. The liquidity position is assessed as medium, with a cu…
The company's capital structure is characterized by a debt-to-equity ratio of 0.94, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.06, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of…
160 Health International Ltd exhibits a negative operating cash flow of -30.64 million CNY and a free cash flow of -37.17 million CNY, indicating significant liquidity constraints. The company's ma…
Zhejiang Sunflower Great Health Co Ltd has a market price of 3.48 CNY per share, with a market capitalization of 4,479,493,284.72 CNY. The company's price-to-book ratio is 6.57, and its price-to-ta…
The company's capital structure is characterized by a debt-to-equity ratio of 0.46, indicating a relatively conservative leverage position compared to the industry median of 0.65. However, the comp…
The company maintains a relatively strong liquidity position, with a current ratio of 2.93, indicating that it has nearly three times as many current assets as current liabilities. However, the com…
Genome&Company Inc has a strong liquidity position, with cash and equivalents amounting to KRW 59,755,466,520, which is significantly higher than its short-term liabilities. The company's liquidity…
Concord Medical Co Ltd has a market capitalization of TWD 1,021,656,450, with a market price of TWD 30.65 per share. The company has 33,333,000 basic and diluted shares outstanding, indicating no i…
Taiwan Biomaterial Co Ltd maintains a strong liquidity position, with a current ratio of 8.53 and cash and equivalents amounting to TWD 258.4 million. The company's debt-to-equity ratio is 0.08, in…
The company maintains a strong liquidity position, with a current ratio of 19.7, indicating a high ability to meet short-term obligations. However, the company is currently unprofitable, with a net…
Yoda Pharmaceuticals Inc has a fully diluted share count of 83,779,018 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or con…
The company maintains a debt-to-equity ratio of 0.96, indicating a moderate level of leverage, while its current ratio of 1.14 suggests limited short-term liquidity. With total cash and equivalents…
The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.31, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medi…
ABAT.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.06, significantly below the industry median, indicating a low reliance on debt financing. The company's liquidity…
Acumen Pharmaceuticals Inc has a liquidity position characterized by a current ratio of 4.07, indicating strong short-term liquidity. The company holds $53.99 million in cash and equivalents, which…
The company maintains a strong liquidity position, with a current ratio of 14.18, indicating a significant ability to meet short-term obligations. However, the company is currently unprofitable, wi…
The company's capital structure shows a debt-to-equity ratio of 0.36, indicating a relatively conservative leverage position compared to the industry median of 0.50. However, liquidity remains a co…
BGDP.WA's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents. This lack of data prevents a meaningfu…
The company's capital structure is characterized by a strong liquidity position, with $92,940 in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The current…
Coeptis Therapeutics operates with a capital structure that includes $250,000 in long-term debt and $13,561,990 in total equity, resulting in a debt-to-equity ratio of 0.02. The company's liquidity…
Cryosite operates with a fully diluted share count of 48.81 million shares, with no additional shares outstanding in the diluted count, indicating no dilution from stock options or convertible inst…
E for L Aim PCL has a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing, and a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-…
The company maintains a strong liquidity position, with a current ratio of 3.88 and cash and equivalents amounting to 29,962,043,500 IDR. The liquidity FPT score indicates a low risk of liquidity d…
Medinice SA has a strong liquidity position, with a current ratio of 6.87, indicating that the company has significantly more current assets than current liabilities. The company's cash and equival…
INOD.NS maintains a strong liquidity position with a current ratio of 5.31, indicating the company can cover its short-term liabilities more than five times over. However, the company's cash and eq…
JPH.PL maintains a strong liquidity position, with a current ratio of 3.41 and $12.2 million in cash and equivalents, indicating the company can easily cover its short-term obligations. The debt-to…
KNE.V exhibits a distressed capital structure with negative total equity of -746,550 CAD and long-term debt of 2,304,310 CAD. The current ratio stands at 0.68, indicating that current liabilities e…
Natural Alternatives International Inc operates with a low debt-to-equity ratio of 0.11 and a strong current ratio of 3.98, indicating robust short-term liquidity. The company's price-to-book ratio…
Nova Consumer Group JSC has a debt-to-equity ratio of 0.75, indicating a moderate level of leverage, and a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its short-t…
Nawaloka Hospitals PLC has a debt-to-equity ratio of 1.58, indicating a relatively high level of leverage, and a current ratio of 0.32, suggesting limited short-term liquidity. The company's free c…
NxN's capital structure is highly leveraged, with total liabilities of AUD 3.37 billion and total equity of AUD -116.24 million, resulting in a debt-to-equity ratio of -26.84. The company's liquidi…
NXTG.TA's capital structure is highly leveraged, with total liabilities of 5.87 million ILS and total equity of -5.52 million ILS, indicating a negative net worth. The company's liquidity position…
PMDI.PK has a liquidity position characterized by $1.42 million in cash and equivalents, with a current ratio of 1.82, indicating a relatively strong ability to meet short-term obligations. However…
POSC.PK's capital structure is highly leveraged, with total liabilities of $2.71 billion and total equity of -$837 million, resulting in a negative debt-to-equity ratio of -0.56. The company's liqu…
Speed Medical SAE has a liquidity ratio of 0.61, indicating that its current assets are less than its current liabilities, which suggests a potential liquidity risk. The company's debt-to-equity ra…
SURI.JK's capital structure and liquidity position show a current ratio of 4.83, indicating strong short-term liquidity. However, the company has a negative net cash position after subtracting tota…
ZENL.BO maintains a strong liquidity position, with cash and equivalents amounting to $3.03 billion, significantly exceeding its total equity of $951,210. The company's debt-to-equity ratio is 0.0,…
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd maintains a debt-to-equity ratio of 0.77, indicating a moderate level of leverage, and a current ratio of 1.88, suggesting it has sufficient shor…
Hefei Lifeon Pharmaceutical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 2.03, indicating that it has more than double the current assets to cover its current li…
Ilsung IS Co Ltd has a strong liquidity position, with a current ratio of 6.69, indicating that the company holds significantly more current assets than current liabilities. The company also mainta…
ZGOO Holdings has a current ratio of 6.61, indicating strong short-term liquidity, but its operating cash flow of -691,003,840 KRW and free cash flow of -276,790,240 KRW suggest ongoing cash flow c…
The company maintains a strong liquidity position, with a current ratio of 17.11, indicating a high ability to meet short-term obligations. The company holds significant cash and equivalents of CNY…
Cloudbreak Pharma Inc has a market capitalization of USD 1.13 billion, with a market price of USD 1.33 per share. The company has no dilution risk, as the number of basic and diluted shares outstan…
Structure and Liquidity Baotou Dongbao Bio-Tech maintains a debt-to-equity ratio of 0.32, indicating a relatively conservative capital structure. The company's liquidity position is assessed as med…
Zhejiang Garden Biopharmaceutical Co Ltd maintains a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure with moderate leverage. The company's liquidity position is asse…
Guangdong Transtek Medical Electronics Co Ltd maintains a strong liquidity position, with a current ratio of 2.62, indicating the company can cover its short-term liabilities more than two times ov…
Zhejiang Benli Technology Co Ltd maintains a strong liquidity position, with a current ratio of 3.97, indicating that it has nearly four times as many current assets as current liabilities. The com…
3176.TWO has a debt-to-equity ratio of 0.59, indicating a moderate level of leverage, and a current ratio of 4.68, suggesting strong short-term liquidity. However, the company's free cash flow is n…
The company maintains a strong liquidity position, with a current ratio of 8.53, indicating a significant ability to meet short-term obligations. The price-to-book ratio of 2.34 suggests that the m…
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 10,808,834,910, which is significantly higher than its total liabilities of KRW 650,874,290, resulting…
NatureWise Biotech & Medicals Corp has a market capitalization of 918,009,975 TWD, with a market price of 19.05 TWD per share. The company has 48,189,500 basic and diluted shares outstanding, indic…
The company maintains a relatively strong liquidity position, with a current ratio of 1.57, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liq…
Jiangsu Lianhuan Pharmaceutical Co Ltd has a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing, and a current ratio of 0.98, suggesting limited short-term liquidity. Th…
ABPH.DH has a fully diluted share count of 2.4 million, matching its basic share count, indicating no dilution from stock options or other convertible instruments. However, liquidity risk could not…
Alps Group Inc has a basic and diluted share count of 172,435,326 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, th…
ALR Technologies SG Ltd has a fully diluted share count of 645,466,844 shares, which is identical to its basic share count, indicating no dilution from stock options, warrants, or convertible secur…
Asiri Surgical Hospital PLC maintains a debt-to-equity ratio of 0.5, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, wit…
Avecho Biotechnology Ltd has a fully diluted share count of 3,673,463,679, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock options…
BLT.NZ maintains a strong liquidity position, with a current ratio of 7.73, indicating that the company has significantly more current assets than current liabilities, and a cash and equivalents ba…
BioMark Diagnostics Inc has a negative equity position of CAD -609,610,000 and a debt-to-equity ratio of -1.32, indicating a leveraged capital structure with liabilities exceeding assets. The compa…
BVS.HN maintains a capital structure with a debt-to-equity ratio of 1.53, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ra…
Carlo Rino Group Bhd has a fully diluted share count of 488,758,548 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible…
COR.CN maintains a strong liquidity position with a current ratio of 0.82, indicating that its current liabilities exceed its current assets. The company's liquidity is assessed as medium, and its…
DEXTECH.TE exhibits a strong liquidity position, with a current ratio of 45.07, indicating that the company holds significantly more current assets than current liabilities. The company has no long…
DVLA.JK maintains a strong liquidity position, with a current ratio of 2.45, indicating that the company has more than twice the current assets to cover its current liabilities. The company's free…
GUFI.NS has a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing, and a current ratio of 1.61, suggesting reasonable short-term liquidity. However, the company's net cas…
HC Surgical Specialists Ltd has a fully diluted share count of 153,375,507, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible…
Itama Ranoraya PT has a debt-to-equity ratio of 0.47, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity is assessed as medium, and it…
Psyence Biomedical has a fully diluted share count of 2,296,207, with no additional shares outstanding in the diluted scenario, indicating no immediate dilution pressure from stock options or conve…
Penta Valent Tbk PT maintains a debt-to-equity ratio of 0.4, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as medium, wi…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage approach, and a strong current ratio of 7.88, suggesting robust short-term…
PTEC.V exhibits a weak capital structure and liquidity position, with a current ratio of 0.9 and a debt-to-equity ratio of 0.6. The company's total liabilities exceed its total assets, and it has a…
Revive Therapeutics has a negative equity position of CAD -3,455,700 and a current ratio of 0.02, indicating severe liquidity constraints. The company's cash and equivalents amount to CAD 14,560, w…
SINR.SI's capital structure shows a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing. The company holds cash and equivalents of SGD 5.2 million, but with long-term debt…
TARA.JK exhibits a strong liquidity position, with a current ratio of 3.21, indicating the company can cover its short-term liabilities more than three times over. The company has no long-term debt…
Vita Life Sciences operates with a fully diluted share count of 54,394,547 shares, with no additional shares outstanding in the diluted count, indicating no dilution from stock options or convertib…
The company maintains a strong liquidity position, with cash and equivalents amounting to CNY 370.2 million, representing 14.9% of total assets. The liquidity FPT (free cash flow to total liabiliti…
Lifecome Biochemistry Co Ltd has a debt-to-equity ratio of 3.52, indicating a high level of leverage, and a current ratio of 0.37, suggesting limited short-term liquidity. The company's operating c…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. However, the company reported a negative operating cash flow of…
The company's capital structure is characterized by a debt-to-equity ratio of 0.21, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, w…
Saudi Chemical Holding Company SJSC maintains a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure. The company's liquidity position is assessed as medium, with a curre…
237690.KQ operates in the pharmaceuticals industry within the health care sector, generating revenue through disclosed business activities. The company is classified under the Pharmaceuticals indus…
MedSci Healthcare Holdings Ltd has a fully diluted share count of 607,170,950 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options…
Hangzhou Diagens Biotechnology Co Ltd has a market capitalization of 33.56 billion CNY, with a market price of 377.6 CNY per share. The company has no dilution risk, as shares outstanding remain un…
Heren Health maintains a strong liquidity position with a current ratio of 3.77, indicating the company can cover its short-term obligations more than three times over. The company's liquidity_fpt…
4115.TWO has a debt-to-equity ratio of 0.51, indicating a moderate level of leverage, and a current ratio of 1.32, suggesting it has sufficient short-term assets to cover its short-term liabilities…
The company maintains a strong liquidity position with a current ratio of 5.1 and cash and equivalents of TWD 106.06 million, which exceeds its total liabilities of TWD 101.30 million. Its debt-to-…
Bioptic Inc has a market capitalization of TWD 1.14 billion, with a market price of TWD 34.6 per share. The company has 33,089,000 basic and diluted shares outstanding, indicating no immediate dilu…
6892.TWO has a market capitalization of 2,592,940,000 TWD and a debt-to-equity ratio of 0.76, indicating a moderate level of leverage. The company's enterprise value to revenue ratio is 62.36, sugg…
Pharmigene Inc has a market capitalization of TWD 474,875,650, with a market price of TWD 9.41 per share. The company has 50,465,000 basic and diluted shares outstanding, indicating no immediate di…
Libo Pharma Corp has a market capitalization of TWD 2.73 billion, with a market price of TWD 36.3 per share, based on the latest available data. The company has 75.235 million shares outstanding, w…
The company maintains a strong liquidity position, with a current ratio of 9.3, indicating a high ability to meet short-term obligations. The liquidity_fpt metric further supports this, showing a r…
The company maintains a debt-to-equity ratio of 1.35, indicating a moderate reliance on debt financing relative to equity. Its liquidity position is characterized as medium, with a current ratio of…
Absci Corp operates in the biotechnology sector within the Health Care industry, generating minimal revenue of $2.8 million while incurring significant operating losses of $120.3 million. The compa…
ALNOV.PA maintains a strong liquidity position, with cash and equivalents amounting to £19.2 million, representing 96% of its total revenue of £20 million. This high liquidity ratio suggests the co…
The company's liquidity position is currently unassessable due to the absence of balance-sheet inputs and no going-concern language in source documents. This lack of data prevents a meaningful eval…
American Oncology Network Inc has a debt-to-equity ratio of 1.36, indicating a moderate level of leverage, while its current ratio of 1.69 suggests it has sufficient short-term assets to cover its…
Aquestive Therapeutics Inc operates in the pharmaceuticals sector, developing and commercializing drug products within the health care industry. The company is classified under the Health Care econ…
Becton Dickinson and Co designs, manufactures, and sells medical devices, instruments, and diagnostic products for healthcare providers and laboratories. The company operates in the Medical Equipme…
BXN.AX maintains a strong liquidity position with a current ratio of 2.46, indicating the company can cover its short-term liabilities more than twice over. The company's debt-to-equity ratio is 0.…
CHER.V's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is reflected in a current ratio of 2.78, sug…
Denis Chem Lab Ltd maintains a strong liquidity position, with a current ratio of 2.55 and cash and equivalents amounting to INR 234.81 million, which represents 21.5% of total assets. The company'…
Enliven Therapeutics Inc is a pharmaceutical company operating in the Health Care sector, focused on drug development within the Pharmaceuticals industry. The company is classified under the Pharma…
Emyria's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and there is no going-concern language in the source documents. This ab…
Genflow Biosciences PLC has a market capitalization of £1.098 billion, with a market price of £2.05 per share, and no dilution risk based on the current share count of 535.65 million shares outstan…
Mukdahan International Hospital PCL has a capital structure with 560 million basic and diluted shares outstanding, indicating no dilution from stock options or convertible instruments. The company…
HSTC.PK exhibits a weak capital structure and liquidity position, with a current ratio of 0.08 and negative free cash flow of -$174,570. The company's debt-to-equity ratio is 0.05, indicating minim…
Lyell Immunopharma Inc operates as a biotechnology company within the Health Care sector, though specific revenue-generating activities are not detailed in the available data. The company is classi…
MMIX.JK's capital structure and liquidity position cannot be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of data prevents a…
Manoj Vaibhav Gems N Jewellers Ltd maintains a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing, while its current ratio of 1.83 suggests reasonable short-term liquidi…
Matricelf operates with a fully diluted share count of 29.24 million shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution pressure from stock op…
Namwiwat Medical Corp PCL maintains a strong liquidity position with a current ratio of 8.91, indicating a high ability to meet short-term obligations. However, the company reported negative operat…
Wattana Karnpaet PCL maintains a strong liquidity position, with a current ratio of 1.5 and cash and equivalents amounting to 44,969,670 THB. The company's liquidity FPT (free cash flow to total li…
NVRS.CD has a negative total equity of -12471360.0, indicating a significant deficit in its capital structure. The company's long-term debt of 9582960.0 further exacerbates its financial position,…
Phaos Technology Holdings (Cayman) Limited has a market capitalization of SGD 35.23 million, with a market price of SGD 2.57 per share. The company has 13.71 million shares outstanding, with no dil…
Replek AD Skopje has a capital structure with 259,200 basic and diluted shares outstanding, indicating no dilution pressure from share-based compensation or convertible instruments. However, liquid…
Syn2bio's capital structure is characterized by a lack of disclosed balance-sheet inputs, which prevents a full liquidity assessment. The company has no dilution risk in the near term, as shares ou…
Suntar Eco-City Ltd's capital structure and liquidity position cannot be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company's liq…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.